Healthcare stocks were leaning lower premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) declining by 0.8% and the iShares Biotechnology ETF (IBB) down 0.1%.
Prime Medicine (PRME) shares were up more than 1% after the company priced a public offering of 35.7 million shares at $3.50 per share to raise roughly $125 million in gross proceeds.
InMode (INMD) stock was up more than 5% after the company reported lower Q3 non-GAAP earnings and revenue that still topped analysts' expectations.
The Federal Trade Commission said it has amended its lawsuit against Hims & Hers Health (HIMS), adding five states as co-plaintiffs in a case alleging the telehealth provider improperly shared consumers' sensitive health information and misled users about billing and subscription cancellations. Shares of Hims & Hers Health were up more than 1% pre-bell.
